These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

378 related items for PubMed ID: 10666371

  • 1. Genetic profile of gliosarcomas.
    Reis RM, Könü-Lebleblicioglu D, Lopes JM, Kleihues P, Ohgaki H.
    Am J Pathol; 2000 Feb; 156(2):425-32. PubMed ID: 10666371
    [Abstract] [Full Text] [Related]

  • 2. Mutations of TP53, amplification of EGFR, MDM2 and CDK4, and deletions of CDKN2A in malignant astrocytomas.
    Biernat W, Debiec-Rychter M, Liberski PP.
    Pol J Pathol; 1998 Feb; 49(4):267-71. PubMed ID: 10323080
    [Abstract] [Full Text] [Related]

  • 3. p53 gene mutation and ink4a-arf deletion appear to be two mutually exclusive events in human glioblastoma.
    Fulci G, Labuhn M, Maier D, Lachat Y, Hausmann O, Hegi ME, Janzer RC, Merlo A, Van Meir EG.
    Oncogene; 2000 Aug 03; 19(33):3816-22. PubMed ID: 10949938
    [Abstract] [Full Text] [Related]

  • 4. Comprehensive analysis of genomic alterations in gliosarcoma and its two tissue components.
    Actor B, Cobbers JM, Büschges R, Wolter M, Knobbe CB, Lichter P, Reifenberger G, Weber RG.
    Genes Chromosomes Cancer; 2002 Aug 03; 34(4):416-27. PubMed ID: 12112531
    [Abstract] [Full Text] [Related]

  • 5. Preferential inactivation of the p53 tumor suppressor pathway and lack of EGFR amplification distinguish de novo high grade pediatric astrocytomas from de novo adult astrocytomas.
    Sung T, Miller DC, Hayes RL, Alonso M, Yee H, Newcomb EW.
    Brain Pathol; 2000 Apr 03; 10(2):249-59. PubMed ID: 10764044
    [Abstract] [Full Text] [Related]

  • 6. Primary glioblastomas with and without EGFR amplification: relationship to genetic alterations and clinicopathological features.
    Benito R, Gil-Benso R, Quilis V, Perez M, Gregori-Romero M, Roldan P, Gonzalez-Darder J, Cerdá-Nicolas M, Lopez-Gines C.
    Neuropathology; 2010 Aug 03; 30(4):392-400. PubMed ID: 20051017
    [Abstract] [Full Text] [Related]

  • 7. Characterisation of molecular alterations in microdissected archival gliomas.
    Walker C, Joyce KA, Thompson-Hehir J, Davies MP, Gibbs FE, Halliwell N, Lloyd BH, Machell Y, Roebuck MM, Salisbury J, Sibson DR, Du Plessis D, Broome J, Rossi ML.
    Acta Neuropathol; 2001 Apr 03; 101(4):321-33. PubMed ID: 11355303
    [Abstract] [Full Text] [Related]

  • 8. Primary and secondary glioblastomas: from concept to clinical diagnosis.
    Kleihues P, Ohgaki H.
    Neuro Oncol; 1999 Jan 03; 1(1):44-51. PubMed ID: 11550301
    [Abstract] [Full Text] [Related]

  • 9. Pilocytic astrocytomas do not show most of the genetic changes commonly seen in diffuse astrocytomas.
    Cheng Y, Pang JC, Ng HK, Ding M, Zhang SF, Zheng J, Liu DG, Poon WS.
    Histopathology; 2000 Nov 03; 37(5):437-44. PubMed ID: 11119125
    [Abstract] [Full Text] [Related]

  • 10. Genetic profile of the giant cell glioblastoma.
    Peraud A, Watanabe K, Schwechheimer K, Yonekawa Y, Kleihues P, Ohgaki H.
    Lab Invest; 1999 Feb 03; 79(2):123-9. PubMed ID: 10068201
    [Abstract] [Full Text] [Related]

  • 11. Roles of the functional loss of p53 and other genes in astrocytoma tumorigenesis and progression.
    Nozaki M, Tada M, Kobayashi H, Zhang CL, Sawamura Y, Abe H, Ishii N, Van Meir EG.
    Neuro Oncol; 1999 Apr 03; 1(2):124-37. PubMed ID: 11550308
    [Abstract] [Full Text] [Related]

  • 12. Gliomatosis cerebri: molecular pathology and clinical course.
    Herrlinger U, Felsberg J, Küker W, Bornemann A, Plasswilm L, Knobbe CB, Strik H, Wick W, Meyermann R, Dichgans J, Bamberg M, Reifenberger G, Weller M.
    Ann Neurol; 2002 Oct 03; 52(4):390-9. PubMed ID: 12325066
    [Abstract] [Full Text] [Related]

  • 13. Molecular genetic correlates of p16, cdk4, and pRb immunohistochemistry in glioblastomas.
    Burns KL, Ueki K, Jhung SL, Koh J, Louis DN.
    J Neuropathol Exp Neurol; 1998 Feb 03; 57(2):122-30. PubMed ID: 9600204
    [Abstract] [Full Text] [Related]

  • 14. PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas.
    Tohma Y, Gratas C, Biernat W, Peraud A, Fukuda M, Yonekawa Y, Kleihues P, Ohgaki H.
    J Neuropathol Exp Neurol; 1998 Jul 03; 57(7):684-9. PubMed ID: 9690672
    [Abstract] [Full Text] [Related]

  • 15. Phenotype vs genotype in the evolution of astrocytic brain tumors.
    Kleihues P, Ohgaki H.
    Toxicol Pathol; 2000 Jul 03; 28(1):164-70. PubMed ID: 10669004
    [Abstract] [Full Text] [Related]

  • 16. Alterations of cell cycle regulatory genes in primary (de novo) and secondary glioblastomas.
    Biernat W, Tohma Y, Yonekawa Y, Kleihues P, Ohgaki H.
    Acta Neuropathol; 1997 Oct 03; 94(4):303-9. PubMed ID: 9341929
    [Abstract] [Full Text] [Related]

  • 17. Investigation of germline PTEN, p53, p16(INK4A)/p14(ARF), and CDK4 alterations in familial glioma.
    Tachibana I, Smith JS, Sato K, Hosek SM, Kimmel DW, Jenkins RB.
    Am J Med Genet; 2000 May 15; 92(2):136-41. PubMed ID: 10797439
    [Abstract] [Full Text] [Related]

  • 18. CDKN2A gene deletions and loss of p16 expression occur in osteosarcomas that lack RB alterations.
    Nielsen GP, Burns KL, Rosenberg AE, Louis DN.
    Am J Pathol; 1998 Jul 15; 153(1):159-63. PubMed ID: 9665476
    [Abstract] [Full Text] [Related]

  • 19. Aberrant expression of the cell cycle associated proteins TP53, MDM2, p21, p27, cdk4, cyclin D1, RB, and EGFR in cervical carcinomas.
    Skomedal H, Kristensen GB, Lie AK, Holm R.
    Gynecol Oncol; 1999 May 15; 73(2):223-8. PubMed ID: 10329038
    [Abstract] [Full Text] [Related]

  • 20. Comparative molecular genetic profiles of anaplastic astrocytomas/glioblastomas multiforme and their subsequent recurrences.
    Saxena A, Shriml LM, Dean M, Ali IU.
    Oncogene; 1999 Feb 11; 18(6):1385-90. PubMed ID: 10022821
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.